# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017315
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:27
Documents
86
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1389832
2 |  | ex31-1.htm | EX-31.1 | 10957
3 |  | ex31-2.htm | EX-31.2 | 11066
4 |  | ex32-1.htm | EX-32.1 | 8107
| Complete submission text file | 0001493152-23-017315.txt |  | 8547030

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | qlgn-20230331.xsd | EX-101.SCH | 69617
6 | XBRL CALCULATION FILE | qlgn-20230331_cal.xml | EX-101.CAL | 77802
7 | XBRL DEFINITION FILE | qlgn-20230331_def.xml | EX-101.DEF | 344351
8 | XBRL LABEL FILE | qlgn-20230331_lab.xml | EX-101.LAB | 547736
9 | XBRL PRESENTATION FILE | qlgn-20230331_pre.xml | EX-101.PRE | 467592
80 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1425662

Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

EIN.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 23922087
SIC: 2834 Pharmaceutical Preparations